(Q40160978)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Michael D Kluger

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Beth A Schrope

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Krishnaraj Mahendraraj

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Elizabeth M Hecht

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Jonathan Susman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Joshua L Weintraub

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

John A Chabot

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

1 reference

29 December 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

Annals of Surgical Oncology

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1736-1743

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer. Definitive results of

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Resection versus other treatments for locally advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Short-term but not long-term loss of patency of venous reconstruction during pancreatic resection is associated with decreased survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Evaluation of thermal injury to liver, pancreas and kidney during irreversible electroporation in an in vivo experimental model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Irreversible electroporation: treatment effect is susceptible to local environment and tissue properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Irreversible electroporation (IRE) fails to demonstrate efficacy in a prospective multicenter phase II trial on lung malignancies: the ALICE trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Irreversible electroporation ablation: is all the damage nonthermal?

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-015-5034-X

10.1245/S10434-015-5034-X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

3 March 2020

1051101346

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26714959%20AND%20SRC:MED&resulttype=core&format=json